[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in bronchopulmonary and pleural cancers].
Centre Eugène-Marquis, Rennes
Patrick
P
Bourguet
D001984:Bronchial Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D010997:Pleural Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000628:therapy; D011379:Prognosis; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014055:Tomography, Emission-Computed / Q000379:methods / Q000592:standards*; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18